- $195.32m
- $131.78m
- $62.45m
- 79
- 39
- 54
- 59
Annual income statement for OptimizeRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 21.2 | 24.6 | 43.3 | 61.3 | 62.5 |
| Cost of Revenue | |||||
| Gross Profit | 12.2 | 15.4 | 24.1 | 35.6 | 39 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 21 | 28.3 | 45.4 | 60.9 | 74.7 |
| Operating Profit | 0.18 | -3.69 | -2.14 | 0.361 | -12.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.226 | -4.04 | -2.21 | 0.378 | -11.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.226 | -3.14 | -2.21 | 0.378 | -11.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.226 | -3.14 | -2.21 | 0.378 | -11.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.226 | -3.14 | -2.21 | 0.378 | -11.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.019 | -0.235 | -0.149 | 0.021 | -0.643 |